Potent broadly reactive neutralising HIV-1 monoclonal antibodies [ 2008 - 2010 ]

Also known as: Generation of anti-HIV-1 antibodies that completely block viral infection

Research Grant

[Cite as]

Researchers: A/Pr Dale Mcphee (Principal investigator) ,  A/Pr Elizabeth Dax Dr Kim Wilson

Brief description A successful vaccine prevents infection. For HIV infection all candidate vaccines thus far have failed. From the many HIV-1 infected individuals there are a very small percentage that do not progress to disease. For these infected subjects we hypothesise that their immune responses are much better preserved and hence they will have stronger antibody responses. We have geared up our laboratory to characterise these strong antibodies and use them in making a better HIV-1 vaccine.

Funding Amount $AUD 463,168.14

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]